https://gprjournals.org/journals/index.php/AJT/issue/feed 2024-06-19T19:25:24+00:00 Open Journal Systems <p><strong>American Journal of Technology</strong> (AJT) is a refereed journal aiming at providing academically robust researches associated with technology-based inventions and innovation. The scope of AJT is Management of Technology including Big Data Analytics, Robotics, Information Technology Developments, Technology Futures, Software Development and Maintenance, etc. AJT is devoted to maintain its credibility amongst scholars, advanced students, reflective practitioners, and readers seeking an update on current experience and future prospects in technology. Manuscripts submitted to this journal are published online and can be printed as hard copies upon author’s request. Papers can be submitted via email to <a href="mailto:journals@gprjournals.org" target="_blank" rel="noopener">journals@gprjournals.org</a> or <a href="https://gprjournals.org/online-submission/">online submission.</a></p> https://gprjournals.org/journals/index.php/AJT/article/view/243 2024-04-03T18:42:01+00:00 Meshack Owira Okok journals@gprjournals.org Jared Deya journals@gprjournals.org Gladys Rotich journals@gprjournals.org

<p><strong>Aim: </strong>The pharmaceutical companies operating in Kenya have not been spared by the environmental turbulence and increased competition since liberalization of the industry. The main objective of the study was to assess the effects of technological capability on the performance of pharmaceutical companies in Kenya.</p> <p><strong>Methods: </strong>The population comprised the 415 pharmaceutical companies that are operating in Kenya. The study used stratified random sampling with sample size of 103 respondents. The study targeted both manufacturers and distributors. Primary and secondary data was collected using a questionnaire covering the five variables and background information. The data was analysed using SPSS version 23.0, descriptive statistics was computed using mean, frequencies, percentages and inferential statistics to test the relationship between the study variables.</p> <p><strong>Results: </strong>The correlation analysis revealed that there was a positive and significant association between technological capability and firm performance (r = 0.685, p = 0.000). Regression of coefficients results revealed that technological capability and firm performance are positively and significantly related (β =0.603, p=0.000). This implies that a unit increase in technological capability would lead to increase in firm performance by 0.603 units.</p> <p><strong>Conclusion: </strong>Technological capability of a firm stands to be one of the main determinants of how well the organization performs in terms of efficiency and effectiveness.</p> <p><strong>Recommendations: </strong>Pharmaceutical companies should embrace information technology by bringing modern and automated means of production as well as information sharing platforms that create the uniqueness, efficiency and effectiveness of their firms.</p>

2024-04-03T00:00:00+00:00 Copyright (c) 2024 American Journal of Technology https://gprjournals.org/journals/index.php/AJT/article/view/261 2024-06-19T19:25:24+00:00 John L Oyono journals@gprjournals.org Moses N Dakeyo journals@gprjournals.org Lilian Tatah journals@gprjournals.org

<p><strong>Aim:</strong> The aim of this study was to analyze the influence of nanotechnology in cancer treatment, with a focus on understanding its potential benefits and applications in improving therapeutic outcomes.</p> <p><strong>Methods:</strong> Databases like PubMed, Scopus, and Google Scholar were used to find qualitative studies, reviews, and theoretical papers. Search terms such as nanotechnology, cancer treatment, qualitative research, patient outcomes, and therapeutic benefits were utilized. The inclusion criteria was studies with qualitative data, expert opinions, case studies, and theoretical discussions published in the last 10 years. Relevant qualitative data on the types of nanotechnologies used, perceived benefits, challenges, and applications were collected.</p> <p><strong>Results:</strong> The study revealed that nanotechnology holds great promise in revolutionizing cancer treatment. Nanoparticles and nanocarriers can be designed and engineered to deliver therapeutic agents directly to cancer cells, enhancing drug efficacy and reducing systemic toxicity. Furthermore, nanoparticles can be utilized for targeted imaging, early detection of cancer, and monitoring treatment response. Nanotechnology-based approaches, such as nanosensors and nanodevices, also show potential for precise diagnosis and personalized medicine in cancer treatment. However, there are still challenges to be addressed, including regulatory considerations, scalability, and long-term safety assessment.</p> <p><strong>Conclusion:</strong> Nanotechnology has the ability to precisely target cancer cells, enhance drug delivery, and enable early detection and monitoring makes nanotechnology a valuable tool in the fight against cancer.</p> <p><strong>Recommendation:</strong> Researchers, clinicians, and policymakers should continue to invest in the development and application of nanotechnology in cancer treatment. Collaboration between disciplines, including material science, biology, and medicine, is crucial to address the challenges associated with translation from the laboratory to the clinic. Also, efforts should be made to ensure the safety, regulatory compliance, and ethical use of nanotechnology in cancer treatment.</p>

2024-06-19T00:00:00+00:00 Copyright (c) 2024 American Journal of Technology